Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 55 results for "Chronic Myeloid Leukemia (CML)".

Thumbnail for Integrating Functional Cellular Profiling With Molecular Diagnostics for Early Prediction of TKI Resistance in CML: Beyond Mutational Analysis

CML - 261

Integrating Functional Cellular Profiling With Molecular Diagnostics for Early Prediction of TKI Resistance in CML: Beyond Mutational Analysis

Nipanshi Tyagi

Poster Presenter: Nipanshi Tyagi

Thumbnail for Deep molecular response duration predicts treatment-free remission in CML rescued after resistance, warning or major molecular response

CML - 310

Deep molecular response duration predicts treatment-free remission in CML rescued after resistance, warning or major molecular response

Delphine Rea

Poster Presenter: Delphine Rea

Previous 1 2 3 4 5 6 7 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Efficacy and Safety of Asciminib as Second-Line or Later Therapy in Chronic-Phase Chronic Myeloid Leukemia: An Updated Systematic Review and Meta-Analysis

CML - 426

Efficacy and Safety of Asciminib as Second-Line or Later Therapy in Chronic-Phase Chronic Myeloid Leukemia: An Updated Systematic Review and Meta-Analysis

Shivam Rainchwar

Poster Presenter: Shivam Rainchwar

Thumbnail for Artificial Intelligence in Chronic Myeloid Leukemia: Assessing the Accuracy and Clinical Utility of Large Language Models

CML - 457

Artificial Intelligence in Chronic Myeloid Leukemia: Assessing the Accuracy and Clinical Utility of Large Language Models

Berkha Rani

Poster Presenter: Berkha Rani

Thumbnail for Temporal And Ethnic Disparities in Mortality due to Hematologic Malignancies in the United States: A 25 Year Nationwide Retrospective Analysis

CML - 462

Temporal And Ethnic Disparities in Mortality due to Hematologic Malignancies in the United States: A 25 Year Nationwide Retrospective Analysis

Palwasha Farooqi

Poster Presenter: Palwasha Farooqi

Thumbnail for Event-Free Survival and Safety With Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia: 5-Year Follow-Up of OPTIC

CML - 516

Event-Free Survival and Safety With Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia: 5-Year Follow-Up of OPTIC

Michael Deininger

Poster Presenter: Michael Deininger

Thumbnail for Trends in Leukemia -related Renal Failure: Longitudinal Insights from CDC Wonder Data(1999-2024)

CML - 523

Trends in Leukemia -related Renal Failure: Longitudinal Insights from CDC Wonder Data(1999-2024)

Juan Moni Pina

Poster Presenter: Juan Moni Pina

Thumbnail for Real-World Evaluation of First-Line and Second-Line Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia in Chronic Phase: The ASC4REAL-2 Phase 4 Study

CML - 541

Real-World Evaluation of First-Line and Second-Line Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia in Chronic Phase: The ASC4REAL-2 Phase 4 Study

Hagop Kantarjian

Poster Presenter: Hagop Kantarjian

Thumbnail for Impact of Posterior Reversible Encephalopathy Syndrome on Hospitalization and Mortality in Tyrosine Kinase Inhibitor-Treated Patients with Hematologic Malignancies: A Real-World Propensity-Matched Analysis

CML - 547

Impact of Posterior Reversible Encephalopathy Syndrome on Hospitalization and Mortality in Tyrosine Kinase Inhibitor-Treated Patients with Hematologic Malignancies: A Real-World Propensity-Matched Analysis

Antonio Arciniegas

Poster Presenter: Antonio Arciniegas

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors